Atlas Trials

Novavax

47 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Novavax

RecordFirmDate
Efficacy and Safety of NVX-CoV2705 (NCT07086222)Novavax2025-11-20
Lot Consistency Study of COVID-19 and Influenza Combination Vaccine (NCT06482359)Novavax2025-02-01
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine (NCT06291857)Novavax2024-12-09
Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine (NCT06485752)Novavax2024-11-01
A Strain Change Study for SARS-CoV-2 rS Vaccines (NCT06409663)Novavax2024-10-14
Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States (NCT06633835)Novavax2024-09-19
Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines (NCT05925127)Novavax2023-10-16
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (NCT05975060)Novavax2023-09-07
Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines (NCT05973006)Novavax2023-08-16
Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines (NCT05875701)Novavax2023-03-28
A Study to Evaluate the Safety and Immunogenicity of COVID-19 and Influenza Combination Vaccine (NCT05519839)Novavax2022-12-30
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (NCT05468736)Novavax2022-07-22
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults (NCT05463068)Novavax2022-07-11
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines (NCT05372588)Novavax2022-05-25
A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19) (NCT05112848)Novavax2022-02-28
Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine (NCT04961541)Novavax2021-09-08
A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2 (NCT04611802)Novavax2020-12-27
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom (NCT04583995)Novavax2020-09-28
A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults (NCT04533399)Novavax2020-08-17
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant (NCT04368988)Novavax2020-05-25
Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults (NCT03658629)Novavax2018-09-24
Evaluation of the Safety and Immunogenicity of a Recombinant Trivalent Nanoparticle Influenza Vaccine With Matrix M-1 Adjuvant (NanoFlu) (NCT03293498)Novavax2017-09-18

Track Novavax automatically

Every clearance here is in the API, with alerts when new ones post.